Skip to main content
Premium Trial:

Request an Annual Quote

Mitsubishi To Sell Waban Software in Japan

NEW YORK (GenomeWeb News) - Mitsubishi Space Software will sell Waban Software’s Waban Explorer PGx and Waban SCE in Japan, the companies said today.
 
Financial terms of the deal were not disclosed.
 
In a statement, Himanshu Oberoi, president of Waban, said the deal grew out of the global growth of clinical pharmacogenomics, biomarker development and personalized medicine and the increased demand in Asia for Waban products.
 
Waban Explorer PGx provides a secure, 21 CFR11-compliant platform for integrating multiple data sources “and enables exploring, browsing, querying and running analyses using multiple analysis tools,” the company said.
 
Waban SCE offers a controlled environment for managing analyses and reporting in a 21 CFR11-compliant manner with a full audit trail and traceability, Waban added.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.